The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

EuroIntervention 2018;13:1565-1573 published online July 2017. DOI: 10.4244/EIJ-D-17-00492

1. Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; 2. Applied Health Research Centre, Li Ka Shing Knowledge Institute of St. Michael’s Hospital, and Department of Medicine, University of Toronto, Toronto, Canada; 3. AMC Hea

Aims: The aim of this meta-analysis was to compare the midterm clinical outcomes of patients treated with an everolimus-eluting bioresorbable vascular scaffold (BVS) versus an everolimus-

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary